Axiom Presents “Preventing Failure: How to leverage people and technology to mitigate common FDA audit findings” at Outsourcing in Clinical Trials Southeast 2021

Axiom Presenting ‘A Global ePRO Case Study’ and Exhibiting at Outsourcing in Clinical Trials Virtual Experience Today

Axiom Case Study, Events, Press Release

TORONTO, May 27, 2020 (GLOBE NEWSWIRE) — Today Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services will be exhibiting and delivering a presentation during the international event Outsourcing in Clinical Trials (“OCT”) Virtual Experience.

The live presentation “A Global ePRO Case Study” will take place at 11:00AM EDT, and will feature Dr. Jai Shetake, Director of Clinical Science and Product Marketing at Axonics Modulation Technologies along with three members of the Axiom team: Andrew Schachter, Founder and CEO, Seth Kaufman, Director of Clinical Management West Coast, and Kaitlyn Townsley Director of Product Innovation.

The group will discuss the critical importance of ePRO/eCOA data in today’s clinical research and present a global case study where the primary endpoint is ePRO driven.  Topics will include key considerations in the design of such a study, key takeaways from the real-life experience and best practices.

“ePRO continues to exponentially grow as a tool to capture key data directly from subjects participating in clinical studies.  This case study will introduce many of the elements and considerations involved in conducting a large scale, international study where the primary endpoint is ePRO driven.  We are thrilled to have Dr. Jai Shetake of Axonics joining us to share her real-life experience in implementing and conducting this study and working with us at Axiom”, shared Andrew Schachter.

To register, please visit:

See on GlobeNewswire